CN103432495A - External medicament for treating scabies - Google Patents
External medicament for treating scabies Download PDFInfo
- Publication number
- CN103432495A CN103432495A CN2013103874474A CN201310387447A CN103432495A CN 103432495 A CN103432495 A CN 103432495A CN 2013103874474 A CN2013103874474 A CN 2013103874474A CN 201310387447 A CN201310387447 A CN 201310387447A CN 103432495 A CN103432495 A CN 103432495A
- Authority
- CN
- China
- Prior art keywords
- scabies
- medicine
- prepared
- external medicament
- sulfur
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an external medicament for treating scabies, which is prepared from bulk drugs of Chinese medicaments. The external medicament is prepared by uniformly mixing sophora flavescens, stemona root, toosendan fruit, cortex dictamni, cortex phellodendri, rhizoma atractylodis, fructus kochiae, dried alum, sulfur and calomel, crushing the drugs into medicinal powder of 80-120 meshes, and mixing the medicinal powder with a common paste base material according to a conventional method to prepare a paste product. The external medicament is prepared from the Chinese medicaments, has the effects of clearing away heat and toxic materials, eliminating dampness and heat and destroying parasites to relieve itching, and can achieve a quick curative effect on treating scabies without side effects.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of scabies, relate in particular to a kind of external used medicine of take treatment scabies prepared as crude drug by Chinese medicine.
Background technology
Scabies is the dermatosis caused due to the sarcoptic mite skin infection, and sarcoptic mite parasitizes in skin, excavate in " tunnel " and produce mechanical stimulus, and secretions and Excreta causes allergic reaction, and causes the infected's skin acutely scratchy, and night more so.The scabies spread speed is fast and infectiousness is very strong, and general sarcoptic mite leaves people's physical ability survival 2~3 days, and the clothes, bedding, footgear, medicated cap, the pillow covering towel that therefore use patient to use can be by indirect infections, and primary disease is multiple is born in winter, and the course of disease is different in size.The scabies site of pathological change is more common in skin wrinkle place and thin tender position.
Summary of the invention
The purpose of this invention is to provide a kind of external used medicine for the treatment of scabies, this medicine is formed and is had heat-clearing and toxic substances removing by Chinese medicine, the dampness heat extraction, and the effect of killing parasites for relieving itching, can play to the treatment of scabies the purpose that curative effect is fast, have no side effect.
External used medicine of the present invention is that the medicine by following parts by weight is that crude drug prepares:
Radix Sophorae Flavescentis 17~32 Radix Stemonae 17~32 Fructus Toosendan 17~32 Cortex Dictamni 7~13
Cortex Phellodendri 10~20 Rhizoma Atractylodis 10~20 Fructus Kochiae 10~20 dried Alumens 3~7
Sulfur 5~10 Calomelass 2~4.
Preferably, external used medicine of the present invention is that the medicine by following parts by weight is that crude drug prepares:
Radix Sophorae Flavescentis 23~28 Radix Stemonae 23~28 Fructus Toosendan 23~28 Cortex Dictamni 9~11
Cortex Phellodendri 14~16 Rhizoma Atractylodis 14~16 Fructus Kochiae 14~16 dried Alumens 4~6
Sulfur 7~8 Calomelass 3~4.
Medicine of the present invention can be made as any exterior-applied formulation on the pharmaceuticss such as liniment, unguentum, powder, and the present invention preferably makes unguentum.
By the concrete preparation method of unguentum of the present invention, be:
Said medicine, by described parts by weight mix homogeneously, is ground into to 80~120 purpose medicated powder, according to a conventional method medicated powder is added in conventional substrate and makes unguentum.
The heat clearing away of this prescription Radix Sophorae Flavescentis, dampness, parasite killing; The gentle lung qi of the Radix Stemonae, parasite killing; Fructus Toosendan removes damp and hot, pain relieving, parasite killing; The Cortex Dictamni dispeiling pathogenic wind and removing dampness, heat-clearing and toxic substances removing; The Cortex Phellodendri heat clearing and damp drying; The Rhizoma Atractylodis spleen invigorating, dampness is warded off dirty; Fructus Kochiae diuresis, clearing away damp-heat; Dried Alumen dampness, removing toxic substances, parasite killing; The sulphur disinfection parasite killing, dampness removing to stop itchin; The Calomelas parasite killing, counteracting toxic substances.All medicines share heat-clearing and toxic substances removing, dampness heat extraction, killing parasites for relieving itching, the purpose that to the treatment of scabies, can play instant effect, have no side effect.
For further investigating clinical efficacy and the safety of medicine of the present invention, select 70 routine scabies patients to carry out clinical observation to the curative effect of medicine of the present invention.
All cases all is diagnosed as scabies with reference to the diagnosis basis in " disease of tcm Standardization of diagnosis and curative effect ".
Diagnosis basis
1. the skin lesion place is the pale red syringe needle that is dispersed in distribution to chestnut rice size pimple, papulovesicle and Cuniculus paca.Pudendum is visible maroon lesser tubercle sometimes.Consciously very itch, night more so;
2 be apt to occur between finger, under wrist, the fossa cubitalis, axil leading edge, breast, the pleat sections such as umbilicus week, groin, also can general whole body, few sending out in women's head-ornaments except the child;
3 have scabies patient close contact history;
4 skin lesion places can find sarcoptic mite.
Therapeutic Method
Adopt paste medicine of the present invention to be treated, smear whole body from cervical region every day, and once, 7 days be a course for the treatment of at night every day.
Criterion of therapeutical effect
Cure: symptom, sign disappear fully, more than three weeks, and recidivist not;
Take a turn for the better: after treatment finishes, pruritus obviously alleviates, and deflorescence is more than 60%;
Do not heal: symptom, the stepless solution of sign, or deflorescence less than 30%.
The all cases efficacy result is in Table 1.
Table 1 all cases efficacy result.
Group | Number of cases | Cure (%) | Take a turn for the better (%) | Do not heal (%) | Total effective rate (%) |
Treatment group | 70 | 68(97.2) | 1(1.4) | 1(1.4) | 69(98.6) |
The specific embodiment
Embodiment 1
Get Radix Sophorae Flavescentis 17g, Radix Stemonae 17g, Fructus Toosendan 17 g, Cortex Dictamni 7 g, Cortex Phellodendri 10 g, Rhizoma Atractylodis 10 g, the Fructus Kochiae 10 g, dried Alumen 3 g, sulfur 5 g, Calomelas 2 g mix homogeneously, be ground into 80~120 purpose medicated powder, medicated powder is mixed with appropriate methylcellulose substrate according to a conventional method, make the unguentum product.
Embodiment 2
Get Radix Sophorae Flavescentis 32 g, the Radix Stemonae 32 g, Fructus Toosendan 32 g, Cortex Dictamni 13 g, Cortex Phellodendri 20 g, Rhizoma Atractylodis 20 g, the Fructus Kochiae 20 g, dried Alumen 7 g, sulfur 10 g, Calomelas 4 g mix homogeneously, be ground into 80~120 purpose medicated powder, medicated powder is made to the unguentum product with paste substrate commonly used according to a conventional method.
Embodiment 3
Radix Sophorae Flavescentis 25 g, the Radix Stemonae 25 g, Fructus Toosendan 25 g, Cortex Dictamni 10 g, Cortex Phellodendri 15 g, Rhizoma Atractylodis 15 g, the Fructus Kochiae 15 g, dried Alumen 5 g, sulfur 8 g, Calomelas 3 g mix homogeneously, be ground into 80~120 purpose medicated powder, makes the powder product.
During use, water reconciles into pasty state and gets final product.
Claims (2)
1. an external used medicine for the treatment of scabies is characterized in that: described external used medicine is that the medicine by following parts by weight is that crude drug prepares:
Radix Sophorae Flavescentis 17~32 Radix Stemonae 17~32 Fructus Toosendan 17~32 Cortex Dictamni 7~13
Cortex Phellodendri 10~20 Rhizoma Atractylodis 10~20 Fructus Kochiae 10~20 dried Alumens 3~7
Sulfur 5~10 Calomelass 2~4.
2. a kind of external used medicine for the treatment of scabies according to claim 1, is characterized in that, described external used medicine is that the medicine by following parts by weight is that crude drug prepares:
Radix Sophorae Flavescentis 23~28 Radix Stemonae 23~28 Fructus Toosendan 23~28 Cortex Dictamni 9~11
Cortex Phellodendri 14~16 Rhizoma Atractylodis 14~16 Fructus Kochiae 14~16 dried Alumens 4~6
Sulfur 7~8 Calomelass 3~4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013103874474A CN103432495A (en) | 2013-08-30 | 2013-08-30 | External medicament for treating scabies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013103874474A CN103432495A (en) | 2013-08-30 | 2013-08-30 | External medicament for treating scabies |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103432495A true CN103432495A (en) | 2013-12-11 |
Family
ID=49686279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013103874474A Pending CN103432495A (en) | 2013-08-30 | 2013-08-30 | External medicament for treating scabies |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103432495A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105521163A (en) * | 2016-01-08 | 2016-04-27 | 黄彩玉 | Medicine for treating scabies in cattle |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1101269A (en) * | 1993-10-08 | 1995-04-12 | 栾兴志 | Medicine for curing dermatosis |
-
2013
- 2013-08-30 CN CN2013103874474A patent/CN103432495A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1101269A (en) * | 1993-10-08 | 1995-04-12 | 栾兴志 | Medicine for curing dermatosis |
Non-Patent Citations (2)
Title |
---|
李国强等: "《皮肤病•性病》", 31 May 1997, 辽宁科学技术出版社 * |
赵新春: "复方硫磺洗剂治疗疥疮200例", 《陕西中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105521163A (en) * | 2016-01-08 | 2016-04-27 | 黄彩玉 | Medicine for treating scabies in cattle |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102755528A (en) | External Chinese medicine for treating bedsore | |
CN102247581B (en) | Medicament for treating myoma of uterus | |
CN104415265A (en) | Ointment for treating onychomycosis and preparation method thereof | |
CN102755573A (en) | External use traditional Chinese medicine for treating onychomycosis | |
CN101856445A (en) | Chinese patent medicament pills for treating femoral head necrosis | |
CN102512559B (en) | Chinese medicinal composition for treating scapulohumeral periarthritis | |
CN103211886A (en) | Medicament for treating rheumatic arthritis | |
CN102847109B (en) | Navel-applied plaster for treating dysmenorrhea and preparation method thereof | |
CN102580142B (en) | Chinese medicinal liniment for postoperative healing of orthopaedic surgery and preparation method | |
CN103432495A (en) | External medicament for treating scabies | |
CN104474528A (en) | Medicine used for drainage detoxification | |
CN102920824B (en) | Liniment for treating bedsore and preparation method thereof | |
CN102716239A (en) | Pharmaceutical composite for treating traumatic injury | |
CN100551394C (en) | Medicine for treating psoriasis | |
CN106309813A (en) | Traditional Chinese medicinal ointment for treating bedsores | |
CN103550620B (en) | A kind of externally-applied medicinal composition treating rheumatalgia | |
CN103623098B (en) | Externally-applied medicine for treating rhinitis and preparation method thereof | |
CN103263641B (en) | Pharmaceutical composition for nursing and preventing postoperative recurrence of endometriosis | |
CN105362758A (en) | Influenza treatment pharmaceutical composition containing radix platycodonis | |
CN102935216B (en) | Traditional Chinese medicinal composition for treating chilblain | |
CN102727636A (en) | Pharmaceutical composition preparation treating traumatic injuries | |
CN103566110A (en) | Bonesetting traditional Chinese medicine | |
CN103845555A (en) | Traditional Chinese medicine for treating lumbocrural pain | |
CN102552503A (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
CN102727699A (en) | Externally used drug for treating rheumatic arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20131211 |
|
RJ01 | Rejection of invention patent application after publication |